- Home
- PGZ vs CBUS Comparison
PGZ vs CBUS Comparison
Compare PGZ & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGZ
- CBUS
- Stock Information
- Founded
- PGZ 2012
- CBUS 2010
- Country
- PGZ United States
- CBUS United States
- Employees
- PGZ N/A
- CBUS N/A
- Industry
- PGZ Investment Managers
- CBUS Agricultural Chemicals
- Sector
- PGZ Finance
- CBUS Industrials
- Exchange
- PGZ Nasdaq
- CBUS Nasdaq
- Market Cap
- PGZ 68.9M
- CBUS 72.0M
- IPO Year
- PGZ N/A
- CBUS 2017
- Fundamental
- Price
- PGZ $10.44
- CBUS $1.38
- Analyst Decision
- PGZ
- CBUS Strong Buy
- Analyst Count
- PGZ 0
- CBUS 3
- Target Price
- PGZ N/A
- CBUS $22.00
- AVG Volume (30 Days)
- PGZ 23.0K
- CBUS 197.4K
- Earning Date
- PGZ 01-01-0001
- CBUS 11-06-2025
- Dividend Yield
- PGZ 12.26%
- CBUS N/A
- EPS Growth
- PGZ N/A
- CBUS N/A
- EPS
- PGZ N/A
- CBUS N/A
- Revenue
- PGZ N/A
- CBUS $4,846,000.00
- Revenue This Year
- PGZ N/A
- CBUS $17.67
- Revenue Next Year
- PGZ N/A
- CBUS $63.43
- P/E Ratio
- PGZ N/A
- CBUS N/A
- Revenue Growth
- PGZ N/A
- CBUS 63.66
- 52 Week Low
- PGZ $8.46
- CBUS $1.20
- 52 Week High
- PGZ $10.59
- CBUS $6.10
- Technical
- Relative Strength Index (RSI)
- PGZ 47.03
- CBUS 48.79
- Support Level
- PGZ $10.41
- CBUS $1.32
- Resistance Level
- PGZ $10.64
- CBUS $1.41
- Average True Range (ATR)
- PGZ 0.08
- CBUS 0.08
- MACD
- PGZ -0.01
- CBUS 0.01
- Stochastic Oscillator
- PGZ 32.56
- CBUS 52.31
About PGZ Principal Real Estate Income Fund of Beneficial Interest
Principal Real Estate Income Fund is a non-diversified, closed-end management investment company. Its investment objective is to provide high current income with capital appreciation by investing in commercial real estate-related securities. The company does its investments in USA, Australia, Japan, France, Great Britain, Canada, Hong Kong, Germany, Singapore, South Korea, British Virgin Islands and more.
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.